Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential effects. Initial findings suggest that this higher dosage may boost the drug's ability to control blood sugar, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully explore the long-t… Read More